Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Cup And Handle Opportunities: Novocure And Reata Pharmaceuticals

Published 07/02/2019, 06:20 AM
Updated 07/09/2023, 06:31 AM

Every week Tech Charts Global Equity Markets report features some of the well-defined, mature classical chart patterns under a lengthy watchlist and the chart pattern breakout signals that took place during that week. Global Equity Markets report covers single stocks from developed, emerging and frontier markets, ETF’s and global equity indices. The report starts with a review section that highlights the important chart developments on global equity benchmarks. This blog post features from the breakout and watchlist sections two bullish cup and handle continuation chart pattern opportunities, listed on the Nasdaq Stock Exchange. You will also find an educational video on cup and handle chart pattern.

NOVOCURE LTD

Novocure Ltd (NASDAQ:NVCR) is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The stock is listed on the Nasdaq Stock Exchange. Price chart formed a 7 month-long cup and handle with the horizontal boundary acting as strong resistance at 54.5 levels. The horizontal boundary was tested several times over the course of the chart pattern. A daily close above 56.5 levels will confirm the breakout from the 7 month-long cup and handle with the possible chart pattern price target of 80 levels. A breakout can push the stock to all-time highs. This week’s price action was a borderline breakout. I will wait for another day of strength to confirm this breakout.

Cup & Handle Price Target - 80

REATA PHARMACEUTICALS INC

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Reata Pharmaceuticals Inc (NASDAQ:RETA). is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The stock is listed on the Nasdaq Stock Exchange. Price chart formed an 8 month-long cup and handle continuation with the horizontal boundary acting as strong resistance at 100 levels. A daily close above 103 levels will confirm the breakout from the 8 month-long cup and handle continuation with the possible chart pattern price target of 146 levels. Breakout can push the stock to all-time highs.

8 Month Long Cup & Handle

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.